Rule 8.3 - INVERNESS MEDICAL INNOVATIONS INC

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing BARCLAYS PLC (Note 1) Company dealt in INVERNESS MEDICAL INNOVATIONS INC Class of relevant security COM STK USD0.001 to which the dealings being disclosed relate (Note 2) Date of dealing 24 July 2009 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant 2,155,892 2.73% 90,493 0.11% securities (2) Derivatives 0 0.00% (other than options) (3) Options and 144,000 0.18% 130,000 0.16% agreements to purchase/sell Total 2,299,892 2.91% 220,493 0.28% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of Long Short relevant security: Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of Securities Price per unit (GBP) Purchase 949 34.94671233 Purchase 400 34.6025 Purchase 6,900 34.8997971 Purchase 300 34.75 Purchase 48 34.7400 USD Purchase 200 34.945 Purchase 200 34.81 Purchase 9,500 34.97305263 Purchase 2,600 34.79384615 Purchase 5,628 35.03370291 Purchase 7,500 34.73626667 Purchase 100 34.7369 Purchase 800 34.69 Purchase 200 34.725 Purchase 100 34.81 Purchase 26,863 34.86086736 Purchase 1,383 34.70758489 Purchase 56 34.7400 USD Purchase 954 34.7400 USD Purchase 1,200 34.7444 Purchase 40 34.74 Purchase 12 34.72 Purchase 3,860 35.09175389 Purchase 20 34.66 Purchase 4,300 34.87651163 Purchase 900 34.79 Purchase 1,495 34.75197324 Purchase 1,000 34.764 Purchase 500 34.758 Purchase 5,400 34.77407407 Purchase 8,700 34.72817241 Purchase 7 34.72 Purchase 100 34.75 Purchase 3,000 34.90839667 Purchase 100 34.695 Purchase 100 34.74 Purchase 12,300 34.82058537 Purchase 1,500 35.21 Purchase 200 35.05 Purchase 1,700 34.59176471 Purchase 300 34 Purchase 100 34.13 Purchase 4,300 34.75181395 Purchase 100 34.7369 Purchase 200 35.2 Purchase 875 35.15628571 Purchase 1,699 35.10001177 Purchase 1,000 35.121 Purchase 726 35.09862259 Purchase 1,700 34.76235294 Sale 7,000 34.7947 USD Sale 125 34.688 Sale 100 34.695 Sale 217 34.73686636 Sale 200 34.72 Sale 200 35.05 Sale 300 35.15666667 Sale 741 34.69493927 Sale 10,600 34.6424 USD Sale 1,300 35.17461538 Sale 3,900 35.01251282 Sale 800 34.7675 USD Sale 678 34.7757 USD Sale 500 34.7675 USD Sale 331 34.7757 USD Sale 261 34.7757 USD Sale 196 34.7757 USD Sale 181 34.7757 USD Sale 127 34.7757 USD Sale 100 34.87 Sale 100 34.7369 Sale 1,200 34.73916667 Sale 100 34.7369 Sale 1,900 34.76056842 Sale 3,300 34.75236364 Sale 1,000 34.75 Sale 3,774 35.12391892 Sale 25,000 35.172 Sale 35,000 34.74872486 Sale 300 34.76666667 Sale 300 34.75666667 Sale 8,400 34.73147619 Sale 3,800 34.73973684 Sale 1,279 34.74257787 Sale 200 34.74 Sale 3,000 34.74433333 Sale 700 34.74428571 Sale 400 34.0325 Sale 7,500 34.736267 Sale 1,200 34.7444 Sale 1,200 34.5925 Sale 200 34.701 Sale 726 35.09862259 Sale 100 34.74 (b) Derivatives transactions (other than options) Product name, Long/Short Number of Price per (e.g. CFD) (Note 6) Securities unit (GBP) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, e.g. Expiry Option money e.g. call selling, securities to price American, date paid/received option purchasing, which the option European etc. per unit (GBP) varying etc. relates (GBP) (ii) Exercising Product name, e.g. Number of Exercise price per call option securities unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION None Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 27 July 2009 Contact name Geoff Smith Telephone number 020 7116 2913 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) Product name, Written or Number of securities Exercise price Type, e.g. Expiry date e.g. call option purchased to which the option (Note 2) American, or derivative relates European etc. Option Purchased -2,000 22.5000 AMER 22/08/2009 Option Purchased -23,600 25.0000 AMER 22/08/2009 Option Purchased -200 35.0000 AMER 21/11/2009 Option Purchased -200 25.0000 AMER 20/02/2010 Option Purchased -400 35.0000 AMER 22/01/2011 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased -600 40.0000 AMER 16/01/2010 Option Purchased -700 40.0000 AMER 20/02/2010 Option Purchased -1,400 30.0000 AMER 22/01/2011 Option Purchased -1,600 30.0000 AMER 22/08/2009 Option Purchased -100 17.5000 AMER 22/08/2009 Option Purchased -1,900 55.0000 AMER 22/01/2011 Option Purchased -100 22.5000 AMER 22/01/2011 Option Purchased -2,500 25.0000 AMER 16/01/2010 Option Purchased -3,200 35.0000 AMER 16/01/2010 Option Purchased -4,300 50.0000 AMER 22/01/2011 Option Purchased -4,400 55.0000 AMER 16/01/2010 Option Purchased -4,600 25.0000 AMER 16/01/2010 Option Purchased -6,000 35.0000 AMER 22/08/2009 Option Purchased -16,100 35.0000 AMER 22/08/2009 Option Purchased -17,300 40.0000 AMER 19/09/2009 Option Purchased -17,900 40.0000 AMER 22/08/2009 Option Purchased -18,000 30.0000 AMER 22/08/2009 Option Purchased -1,700 30.0000 AMER 21/11/2009 Option Purchased 600 22.5000 AMER 22/08/2009 Option Purchased 22,400 25.0000 AMER 22/08/2009 Option Purchased 6,900 30.0000 AMER 16/01/2010 Option Purchased 6,400 30.0000 AMER 16/01/2010 Option Purchased 4,400 20.0000 AMER 16/01/2010 Option Purchased 2,700 45.0000 AMER 21/11/2009 Option Purchased 2,600 50.0000 AMER 16/01/2010 Option Purchased 2,300 45.0000 AMER 16/01/2010 Option Purchased 1,800 40.0000 AMER 22/01/2011 Option Purchased 1,500 40.0000 AMER 21/11/2009 Option Purchased 1,400 30.0000 AMER 21/11/2009 Option Purchased -100 17.5000 AMER 16/01/2010 Option Purchased 900 25.0000 AMER 22/01/2011 Option Purchased 87,900 35.0000 AMER 22/08/2009 Option Purchased 400 50.0000 AMER 21/11/2009 Option Purchased 200 15.0000 AMER 22/01/2011 Option Purchased 100 35.0000 AMER 20/02/2010 Option Purchased 100 35.0000 AMER 21/11/2009 Option Purchased 100 22.5000 AMER 22/01/2011 Option Purchased 100 20.0000 AMER 16/01/2010 Option Purchased 100 17.5000 AMER 22/01/2011 Option Purchased 100 15.0000 AMER 16/01/2010 Option Purchased 100 12.5000 AMER 22/01/2011 Option Purchased -100 25.0000 AMER 21/11/2009 Option Purchased 900 35.0000 AMER 16/01/2010 Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

Companies

Barclays (BARC)
UK 100

Latest directors dealings